TerrAscend (TSNDF) and Its Rivals Critical Contrast

TerrAscend (OTCMKTS:TSNDF) is one of 43 publicly-traded companies in the “Agricultural production – crops” industry, but how does it compare to its rivals? We will compare TerrAscend to related companies based on the strength of its dividends, analyst recommendations, institutional ownership, profitability, earnings, valuation and risk.

Profitability

This table compares TerrAscend and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TerrAscend	-23.95%	-31.48%	-11.40%
TerrAscend Competitors	-98.15%	-2,439.03%	-14.56%

Risk and Volatility

TerrAscend has a beta of 1.64, indicating that its stock price is 64% more volatile than the S&P 500. Comparatively, TerrAscend’s rivals have a beta of -19.60, indicating that their average stock price is 2,060% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for TerrAscend and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TerrAscend	0	1	0	1	3.00
TerrAscend Competitors	316	259	605	34	2.29

As a group, “Agricultural production – crops” companies have a potential upside of 54.03%. Given TerrAscend’s rivals higher probable upside, analysts clearly believe TerrAscend has less favorable growth aspects than its rivals.

Insider and Institutional Ownership

5.8% of TerrAscend shares are owned by institutional investors. Comparatively, 20.7% of shares of all “Agricultural production – crops” companies are owned by institutional investors. 31.9% of TerrAscend shares are owned by insiders. Comparatively, 16.0% of shares of all “Agricultural production – crops” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Earnings & Valuation

This table compares TerrAscend and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
TerrAscend	$317.33 million	-$95.54 million	-1.57
TerrAscend Competitors	$1.22 billion	-$827,419.35	6.91

TerrAscend’s rivals have higher revenue and earnings than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

TerrAscend beats its rivals on 7 of the 13 factors compared.

About TerrAscend

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.